van der Meche F[au] - Search Results

Year	Number of Results
1971	1
1973	2
1974	1
1975	3
1976	1
1977	1
1983	1
1985	3
1986	3
1987	1
1988	4
1989	4
1991	7
1992	3
1993	3
1994	8
1995	10
1996	7
1997	13
1998	6
1999	7
2000	14
2001	9
2002	8
2003	5
2004	1
2005	2
2006	4
2010	1
2012	1
2022	0

1

The Guillain-Barré syndrome.

Van der Meché FG. Van der Meché FG. Baillieres Clin Neurol. 1994 Apr;3(1):73-94. Baillieres Clin Neurol. 1994. PMID: 7921592 Review. No abstract available.

2

Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies.

Hartung HP, van der Meché FG, Pollard JD. Hartung HP, et al. Among authors: van der meche fg. Curr Opin Neurol. 1998 Oct;11(5):497-513. doi: 10.1097/00019052-199810000-00013. Curr Opin Neurol. 1998. PMID: 9848000 Review. No abstract available.

3

Corticosteroids for treating Guillain-Barré syndrome.

Hughes RA, van der Meché FG. Hughes RA, et al. Among authors: van der meche fg. Cochrane Database Syst Rev. 2000;(2):CD001446. doi: 10.1002/14651858.CD001446. Cochrane Database Syst Rev. 2000. PMID: 10796795 Updated. Review.

4

Corticosteroids for treating Guillain-Barré syndrome.

Hughes RA, van Der Meché FG. Hughes RA, et al. Among authors: van der meche fg. Cochrane Database Syst Rev. 2000;(3):CD001446. doi: 10.1002/14651858.CD001446. Cochrane Database Syst Rev. 2000. PMID: 10908498 Updated. Review.

5

Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.

van der Meché FG, Visser LH, Jacobs BC, Endtz HP, Meulstee J, van Doorn PA. van der Meché FG, et al. J Infect Dis. 1997 Dec;176 Suppl 2:S99-102. doi: 10.1086/513779. J Infect Dis. 1997. PMID: 9396690 Review.

6

Diagnostic and classification criteria for the Guillain-Barré syndrome.

Van der Meché FG, Van Doorn PA, Meulstee J, Jennekens FG; GBS-consensus group of the Dutch Neuromuscular Research Support Centre. Van der Meché FG, et al. Eur Neurol. 2001;45(3):133-9. doi: 10.1159/000052111. Eur Neurol. 2001. PMID: 11306855 Review.

7

The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.

van der Meché FG. van der Meché FG. J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):33-4. doi: 10.1136/jnnp.57.suppl.33. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964849 Free PMC article. Review. No abstract available.

8

Inflammatory neuropathies--pathogenesis and the role of intravenous immune globulin.

van der Meché FG, van Doorn PA, Jacobs BC. van der Meché FG, et al. J Clin Immunol. 1995 Nov;15(6 Suppl):63S-69S. doi: 10.1007/BF01540895. J Clin Immunol. 1995. PMID: 8613494 Review.

9

The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders.

van der Meché FG, van Doorn PA. van der Meché FG, et al. Muscle Nerve. 1997 Feb;20(2):136-47. doi: 10.1002/(sici)1097-4598(199702)20:2<136::aid-mus1>3.0.co;2-d. Muscle Nerve. 1997. PMID: 9040650 Review.

10

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.

van der Meché FG, van Doorn PA. van der Meché FG, et al. Ann Neurol. 1995 May;37 Suppl 1:S14-31. doi: 10.1002/ana.410370704. Ann Neurol. 1995. PMID: 8968214 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results